TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish Biomedical Consulting AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
36
|
3
|
23 |
| Financial expenses |
0
|
0
|
4 |
| Earnings before taxes |
25
|
27
|
10 |
| EBITDA |
25
|
-4
|
14 |
| Total assets |
46
|
65
|
39 |
| Current assets |
46
|
65
|
39 |
| Current liabilities |
9
|
30
|
21 |
| Equity capital |
37
|
35
|
18 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
80.4%
|
53.8%
|
46.2% |
| Turnover per employee |
36
|
3
|
23 |
| Profit as a percentage of turnover |
69.4%
|
900%
|
43.5% |
| Return on assets (ROA) |
54.3%
|
41.5%
|
35.9% |
| Current ratio |
511.1%
|
216.7%
|
185.7% |
| Return on equity (ROE) |
67.6%
|
77.1%
|
55.6% |
| Change turnover |
33
|
-20
|
9 |
| Change turnover % |
1184%
|
-88%
|
62% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.